Tulmimetostat (CPI-0209) in Patients With Mycosis Fungoides and S ézary Syndrome

Conditions:   Mycosis Fungoides;   Sezary Syndrome;   Mycosis Fungoides/Sezary Syndrome Intervention:   Drug: Tulmimetostat Sponsors:   Washington University School of Medicine;   MorphoSys AG Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials